| DC Field | Value | Language |
|---|
| dc.contributor.author | Korokina, L. V. | - |
| dc.date.accessioned | 2024-03-19T08:51:03Z | - |
| dc.date.available | 2024-03-19T08:51:03Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Korokina, L.V. The EPOR/CD131 heteroreceptoragonist has an endothelioprotective effect against the background of pulmonary hypertension caused by monocrotalin / L.V. Korokina // Research Results in Pharmacology. - 2023. - Vol.9, №4.-P. 65-74. - Doi: 10.18413/rrpharmacology.9.10057. - Refer.: p. 74. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/61410 | - |
| dc.description.abstract | Aim: research the possibilities of pharmacological correction of pulmonary arterial hypertension induced by monocrotalin using the EPOR/CD131 heteroreceptor agonist with the laboratory code EP-11-3 | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | monocrotaline | ru |
| dc.subject | EPOR/CD131 | ru |
| dc.subject | endothelial cells | ru |
| dc.subject | endothelioprotector | ru |
| dc.subject | pulmonary hypertension | ru |
| dc.title | The EPOR/CD131 heteroreceptoragonist has an endothelioprotective effect against the background of pulmonary hypertension caused by monocrotalin | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 4
|
